Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend

May 30, 2013

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend, one of Norway’s largest veterinary clinics. A joint project is planned for the construction of a new veterinary hospital in Bergen. Djursjukhusgruppen is the Nordic region’s leading group of companies providing advanced veterinary care for dogs, cats and other pets.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alexandra Kempe, Magnus Wieslander and Gustav Jönsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026